GlassScriptPhysician profile
Meena Moossavi
NPI 1982716114
$1,234.09
in general payments reported to CMS, 2019-2025
19 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $337 · 2020: $28.93 · 2021: $52.62 · 2022: $50.21 · 2023: $207 · 2024: $304 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $765.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qiagen, LLC | $247.98 | 2019 | |
| Abbvie INC. | $193.05 | 2019-2025 | |
| Genzyme Corporation | $137.45 | 2025 | |
| Progenacare Global, LLC | $125.48 | 2023 | |
| Helsinn Therapeutics (U.S.), INC. | $81.12 | 2020-2024 | Valchlor |
| Biofrontera INC. | $73.27 | 2023-2024 | Ameluz, Xepi, Bf-Rhodoled |
| Organogenesis INC. | $47.62 | 2023-2024 | Puraply |
| Cashflow Solutions, LLC | $44.46 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Galderma Laboratories, L.P. | $37.89 | 2025 | Nemluvio |
| Allergan, INC. | $34.39 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $30.19 | 2024 | Dupixent |
| Janssen Scientific Affairs, LLC | $27.15 | 2024 | Tremfya |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.27 | 2024 | Spevigo |
| Chiesi USA, INC. | $25.39 | 2024 | Filsuvez |
| Janssen Biotech, INC. | $25.28 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tactile Systems Technology INC | $21.95 | 2024 | Entre Plus, Flexitouch Plus |
| Kyowa Kirin, INC. | $19.43 | 2025 | |
| Leo Pharma INC. | $18.32 | 2022 | |
| Sun Pharmaceutical Industries INC. | $17.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meena Moossavi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.